28-04-2025
Break it Down: Recce partners with the US Army
Stockhead's Break it Down brings you today's leading market news in under 90 seconds.
Recce Pharmaceuticals (ASX:RCE)has partnered with the US Army Medical Research Institute of Infectious Diseases in an R&D deal focused on its anti-infective drug R327.
Watch the video to learn more.
While Recce Pharmaceuticals is a Stockhead advertiser, it did not sponsor this content.
Originally published as Break it Down: Recce partners with the US Army
